Realta Investment Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Realta Investment Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,270	Closed	–	–	1874
2019 Q1	$0	Buy	+2,270	New	+$578	﹤0.01%	1369

Realta Investment Advisors's SGYP Position: Q2 2019 in Review

Realta Investment Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 2,270 shares.

Realta Investment Advisors first reported a position in SGYP in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.

Realta Investment Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
Realta Investment Advisors sold 2,270 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019.
Realta Investment Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2019 and held it in 1 quarter.
Realta Investment Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $0 in Q1 2019.
2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.

Based on Realta Investment Advisors's 13F filing for Q2 2019, filed 1 Aug 2019.